stella
beta
The Efficacy of Watch and Wait Strategy or Surgery After Neoadjuvant Immunotherapy for Locally Advanced Colorectal Cancer With dMMR/MSI-H Guided by MRD Dynamic Monitoring: A Single-center, Open-label, Prospective, Phase II Clinical Trial. — Stella
Home
/
Clinical Complete Response Rate With Negative MRD
/
View on ClinicalTrials.gov
Recruiting
Back to Clinical Complete Response Rate With Negative MRD trials
Trial locations
(1 site)
China
Yunnan Cancer Hospital, Kunming, Yunnan